cinobufacini
Animal productexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
1
Earliest trial started Jun 1, 2007 (NCT00837239)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cinobufacini
- huachansu
- huachansu
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03843229 | Phase 4 | Jan 27, 2019 | Dalian Medical University |
| NCT02647125 | Phase 2 | Oct 1, 2015 | Fudan University |
| NCT01715532 | Phase 2 | Jul 1, 2012 | Fudan University |
| NCT00837239 | Phase 2 | Jun 1, 2007 | National Cancer Institute (NCI), University of Texas at Houston |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fudan University | Academic/Hospital | 2 | 2 | 1 | 2012 |
| Dalian Medical University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2007 |
| University of Texas at Houston | Academic/Hospital | 1 | 1 | 1 | 2007 |
4 organizations
Page 1 / 1